FGEN Insider Trading Activity and SEC Form 4 Filings
FGEN insider trading summary
Over the past 12 months, insiders at Fibrogen Inc (FGEN) reported 2 open-market purchases worth $34K by 1 insider and no sales on SEC Form 4. Net insider buying was $34K.
Latest FGEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 17, 2025 | Thane Wettig | CEO | Buy | $25K (2,700 @ $9.10) |
| Nov 13, 2025 | Thane Wettig | CEO | Buy | $9K (1,000 @ $9.18) |
| Jun 30, 2025 | James A Schoeneck | Insider | Buy | $119K (23,567 @ $5.07) |
| Mar 24, 2025 | Thane Wettig | CEO | Buy | $51K (145,000 @ $0.35) |
| Mar 21, 2025 | James A Schoeneck | Insider | Buy | $17K (50,000 @ $0.34) |
| Mar 20, 2025 | James A Schoeneck | Insider | Buy | $88K (250,000 @ $0.35) |
| Jun 12, 2024 | Deyaa Adib | Chief Medical Officer | Buy | $26K (22,123 @ $1.17) |
| Mar 7, 2024 | Thane Wettig | CEO | Buy | $95K (50,000 @ $1.91) |
| Sep 1, 2023 | Jeffrey William Henderson | Director | Sell | $2K (2,000 @ $1.03) |
| Aug 4, 2023 | Jeffrey William Henderson | Director | Sell | $4K (2,000 @ $1.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.